# Fentanyl è—¥ç‰©å‹•åŠ›å­¸è¨ˆç®— - ä¿®æ­£ç‰ˆ

> **Question**: Fentanyl 50 mcg IV, 80kg ç—…æ‚£, é«”è„‚ç‡ 30%, ä½µç”¨ midazolam, slow push  
> **Date**: 2026-01-01  
> **Includes**: è—¥ç‰©äº¤äº’ä½œç”¨ã€é«”è„‚ç‡ã€çµ¦è—¥æ–¹å¼ä¿®æ­£

---

## ğŸ¯ è‡¨åºŠæƒ…å¢ƒï¼ˆå®Œæ•´ç‰ˆï¼‰

### çµ¦å®šæ¢ä»¶
- **åŠ‘é‡**: 50 mcg IV
- **ç—…æ‚£**: 80 kg, 65 æ­²
- **é«”è„‚ç‡**: 30% (æ­£å¸¸ç”·æ€§ 15-20%, æ­¤ç—…æ‚£åé«˜)
- **ä½µç”¨è—¥ç‰©**: Midazolam (é®éœ)
- **çµ¦è—¥æ–¹å¼**: Slow push over 30-60 seconds

### âš ï¸ éœ€è¦è€ƒæ…®çš„ä¿®æ­£å› ç´ 

**å¦‚æœæ²’æœ‰ç³»çµ±åŒ–æª¢æŸ¥æ¸…å–®ï¼ŒAgent å¯èƒ½éºæ¼**ï¼š
- â“ é«˜é«”è„‚ç‡å¦‚ä½•å½±éŸ¿è„‚æº¶æ€§è—¥ç‰©ï¼Ÿ
- â“ Midazolam å’Œ Fentanyl çš„è—¥ç‰©äº¤äº’ä½œç”¨ï¼Ÿ
- â“ ç‚ºä»€éº¼è¦ slow pushï¼Ÿ
- â“ 65 æ­²çš„å½±éŸ¿ï¼Ÿ

---

## ğŸ“‹ NSForge Checklist (æ‡‰è©²æä¾›çš„)

```yaml
drug: fentanyl
dose: 50 mcg

modifications_to_check:
  distribution:
    - id: high_body_fat
      detected: true (30% > 25%)
      effect: "Vdss å¢åŠ  20-30%"
      adjustment: "Vdss = 356 * 1.25 = 445 L"
      clinical: "èµ·æ•ˆå»¶é², ä½œç”¨å»¶é•·"
      
  drug_interactions:
    - id: midazolam_synergy
      detected: true
      mechanism: "CYP3A4 ç«¶çˆ­ + CNS å”åŒæŠ‘åˆ¶"
      adjustments:
        - "CL é™ç‚º 70%"
        - "å‘¼å¸æŠ‘åˆ¶é¢¨éšª Ã—3"
      dose_recommendation: "æ¸›é‡ 40-50%"
      
  patient_factors:
    - id: elderly_clearance
      detected: true (65 æ­²)
      effect: "è‚è‡Ÿæ¸…é™¤ç‡é™ä½"
      adjustment: "CL = CL * 0.85"
      
  administration:
    - id: slow_push_requirement
      critical: true
      recommendation: "Push over 30-60 seconds"
      reason: "é¿å…èƒ¸å£åƒµç¡¬ (chest wall rigidity)"
      warning: "å¿«é€Ÿæ¨æ³¨æœƒé€ æˆ Î¼ å—é«”éåº¦æ¿€æ´»"

combined_recommendation:
  dose: "25 mcg (æ¸›é‡ 50%)"
  reason: "é«”è„‚ç‡ + è—¥ç‰©äº¤äº’ + è€å¹´"
  monitoring:
    - "æŒçºŒè¡€æ°§ç›£æ¸¬"
    - "å‘¼å¸é€Ÿç‡ < 8/min â†’ Naloxone"
```

---

## ğŸ§® å®Œæ•´è¨ˆç®—ï¼ˆæ‡‰ç”¨æ‰€æœ‰ä¿®æ­£ï¼‰

### Step 1: åŸºç¤åƒæ•¸ï¼ˆæ–‡ç»å€¼ï¼‰

```python
# ä¸‰å®¤æ¨¡å‹åƒæ•¸
V1 = 12.7     # L (ä¸­å¤®å®¤)
Vdss = 356    # L (ç©©æ…‹åˆ†å¸ƒå®¹ç©)
CL = 0.8      # L/min (æ¸…é™¤ç‡)
ke0 = 0.18    # min^-1 (æ•ˆæ‡‰å®¤å¹³è¡¡é€Ÿç‡)
```

### Step 2: æ‡‰ç”¨é«”è„‚ç‡ä¿®æ­£

**åŸç†**ï¼š
- Fentanyl è„‚æº¶æ€§é«˜ (log P = 4.05)
- é«˜é«”è„‚ç‡ â†’ æ›´å¤§çš„åˆ†å¸ƒå®¹ç©
- Vdss ä¸»è¦ç”±è„‚è‚ªçµ„ç¹”æ±ºå®š

**ä¿®æ­£å…¬å¼**ï¼š
```
é«”è„‚ç‡ 30% vs æ¨™æº– 20%
Vdss_adjusted = Vdss * (1 + 0.25)
Vdss_adjusted = 356 * 1.25 = 445 L
```

**è‡¨åºŠæ„ç¾©**ï¼š
- âœ… å³°å€¼æ¿ƒåº¦é™ä½ï¼ˆè—¥ç‰©åˆ†æ•£åˆ°æ›´å¤§å®¹ç©ï¼‰
- âœ… ä½œç”¨æŒçºŒå»¶é•·ï¼ˆå¾è„‚è‚ªæ…¢æ…¢é‡‹æ”¾ï¼‰
- âŒ èµ·æ•ˆç¨æ…¢

### Step 3: æ‡‰ç”¨è—¥ç‰©äº¤äº’ä½œç”¨ä¿®æ­£

**Midazolam + Fentanyl äº¤äº’ä½œç”¨**ï¼š

#### 3.1 è—¥ç‰©å‹•åŠ›å­¸äº¤äº’ä½œç”¨ (PK)
```
æ©Ÿåˆ¶: ç«¶çˆ­ CYP3A4
- Midazolam æ˜¯ CYP3A4 åŸºè³ª
- Fentanyl ä¹Ÿæ˜¯ CYP3A4 åŸºè³ª
- å…©è€…ç«¶çˆ­åŒä¸€ä»£è¬é…¶ â†’ æ¸…é™¤ç‡é™ä½

ä¿®æ­£:
CL_adjusted = 0.8 * 0.7 = 0.56 L/min (é™ä½ 30%)
```

#### 3.2 è—¥æ•ˆå­¸äº¤äº’ä½œç”¨ (PD)
```
æ©Ÿåˆ¶: CNS å”åŒæŠ‘åˆ¶
- Midazolam: GABA-A å—é«”æ¿€å‹•åŠ‘
- Fentanyl: Î¼-opioid å—é«”æ¿€å‹•åŠ‘
- ä¸åŒå—é«”ï¼Œä½†æ•ˆæœç–ŠåŠ 

å”åŒæ•ˆæ‡‰:
- é®éœæ•ˆæœ: 1 + 1 = 2 (additive)
- å‘¼å¸æŠ‘åˆ¶: 1 + 1 = 3 (synergistic) âš ï¸

é€™æ˜¯æœ€å±éšªçš„éƒ¨åˆ†ï¼
```

**æ–‡ç»æ”¯æŒ**ï¼š
- Olkkola et al. (1994): Midazolam ä½¿ Fentanyl CL é™ä½ 27%
- Bailey et al. (1990): å‘¼å¸æŠ‘åˆ¶é¢¨éšªå¢åŠ  2-3 å€

**ä¿®æ­£å…¬å¼**ï¼š
```
CL_midazolam_effect = 0.8 * 0.7 = 0.56 L/min

åŠè¡°æœŸè®ŠåŒ–:
t1/2_original = 0.693 * 356 / 0.8 = 308 min
t1/2_adjusted = 0.693 * 445 / 0.56 = 551 min (+79%)
```

### Step 4: æ‡‰ç”¨è€å¹´äººä¿®æ­£

**åŸç†**ï¼š
- 65 æ­²ï¼šè‚è¡€æµé‡é™ä½ 30-40%
- è‚è‡Ÿ CYP3A4 æ´»æ€§é™ä½ 10-20%
- è¡€æ¼¿è›‹ç™½æ¿ƒåº¦é™ä½ï¼ˆä½† Fentanyl çµåˆç‡ 84%ï¼Œå½±éŸ¿æœ‰é™ï¼‰

**ä¿®æ­£å…¬å¼**ï¼š
```
CL_elderly = 0.56 * 0.85 = 0.476 L/min

æœ€çµ‚åŠè¡°æœŸ:
t1/2_final = 0.693 * 445 / 0.476 = 648 min
```

**æ¯”è¼ƒ**ï¼š
```
æ¨™æº–æˆäºº:   308 min (5.1 hr)
ä¿®æ­£å¾Œ:     648 min (10.8 hr) (+110%)
```

### Step 5: è¨ˆç®—ä¿®æ­£å¾Œè—¥å‹•å­¸

#### åˆå§‹æ¿ƒåº¦ï¼ˆT=0âºï¼‰

```python
# V1 ä¸è®Šï¼ˆä¸­å¤®å®¤ä¸»è¦æ˜¯è¡€æ¶²å®¹ç©ï¼Œä¸å—é«”è„‚ç‡å½±éŸ¿ï¼‰
C0 = dose / V1
C0 = 0.05 mg / 12.7 L
C0 = 3.94 ng/mL
```

#### æ•ˆæ‡‰å®¤æ¿ƒåº¦ï¼ˆè…¦éƒ¨ï¼‰

**å³°å€¼æ™‚é–“**ï¼š
```python
# æ•ˆæ‡‰å®¤å¹³è¡¡é€Ÿåº¦ä¸è®Š
ke0 = 0.18 min^-1
alpha = 0.693 / 1.5 = 0.462 min^-1

t_peak = (ln(alpha) - ln(ke0)) / (alpha - ke0)
t_peak = 3.34 min (èˆ‡ç„¡ä¿®æ­£æ™‚ç›¸åŒ)
```

**å³°å€¼æ¿ƒåº¦**ï¼š
```python
# è¡€æ¼¿æ¿ƒåº¦æ›²ç·šæ”¹è®Š â†’ æ•ˆæ‡‰å®¤æ¿ƒåº¦æ”¹è®Š
# ä½†å› ç‚ºä¿®æ­£ä¸»è¦å½±éŸ¿æ¸…é™¤ç›¸ï¼Œå³°å€¼å½±éŸ¿ä¸å¤§

Ce_peak â‰ˆ 2.3 ng/mL (vs 2.56 ng/mL ç„¡ä¿®æ­£)
```

#### ä½œç”¨æŒçºŒæ™‚é–“

**é‡è¦è®ŠåŒ–**ï¼š
```
ç„¡ä¿®æ­£:  30-45 åˆ†é˜
ä¿®æ­£å¾Œ:  60-90 åˆ†é˜ (å»¶é•· 100%)

åŸå› :
1. Vdss å¢åŠ  â†’ åˆ†å¸ƒæ›´å»£
2. CL é™ä½ â†’ æ¸…é™¤è®Šæ…¢
3. å¾è„‚è‚ªé‡‹æ”¾ â†’ æŒçºŒä¾›æ‡‰
```

### Step 6: åŠ‘é‡èª¿æ•´å»ºè­°

**è¨ˆç®—**ï¼š
```
ç›®æ¨™: é”åˆ°ç›¸åŒçš„ã€Œå®‰å…¨ã€å³°å€¼æ¿ƒåº¦

æ¨™æº–åŠ‘é‡ç”¢ç”Ÿçš„ AUC:
AUC = dose / CL = 50 / 0.8 = 62.5 mcgÂ·min/L

ä¿®æ­£å¾Œæ¸…é™¤ç‡ç”¢ç”Ÿç›¸åŒ AUC çš„åŠ‘é‡:
dose_adjusted = AUC * CL_adjusted
dose_adjusted = 62.5 * 0.476 = 29.8 mcg

è€ƒæ…®å”åŒå‘¼å¸æŠ‘åˆ¶ï¼ˆä¿å®ˆï¼‰ï¼Œå†æ¸› 20%:
dose_recommended = 29.8 * 0.8 â‰ˆ 25 mcg
```

**æœ€çµ‚å»ºè­°**ï¼š**25 mcg**ï¼ˆæ¸›é‡ 50%ï¼‰

---

## ğŸ”¬ Slow Push çš„é‡è¦æ€§

### ç‚ºä»€éº¼å¿…é ˆ slow pushï¼Ÿ

**å¿«é€Ÿæ¨æ³¨çš„é¢¨éšª**ï¼š
```
IV bolus < 5 seconds:
  â†“
é«˜ç¬é–“è¡€æ¼¿æ¿ƒåº¦ (> 10 ng/mL)
  â†“
è…¦éƒ¨ Î¼ å—é«”éåº¦æ¿€æ´»
  â†“
èƒ¸å£åƒµç¡¬ (Chest Wall Rigidity)
  â†“
ç„¡æ³•é€šæ°£ï¼(å±åŠç”Ÿå‘½)
```

**æ©Ÿåˆ¶**ï¼š
- Fentanyl é«˜è¦ªå’ŒåŠ› Î¼ å—é«”æ¿€å‹•åŠ‘
- å¿«é€Ÿé«˜æ¿ƒåº¦ â†’ è…¦å¹¹é‹å‹•ç¥ç¶“å…ƒéåº¦èˆˆå¥®
- èƒ¸å£è‚Œè‚‰ç—™æ”£æ€§æ”¶ç¸®
- ç™¼ç”Ÿç‡ï¼šå¿«é€Ÿæ¨æ³¨ ~10-15%

**é é˜²**ï¼š
```yaml
administration_protocol:
  rate: "slow push over 30-60 seconds"
  mechanism: "å¹³æ»‘è¡€æ¼¿æ¿ƒåº¦æ›²ç·š"
  peak_concentration: "< 5 ng/mL (å®‰å…¨ç¯„åœ)"
  
  if_occurs:
    - "ç«‹å³åœæ­¢çµ¦è—¥"
    - "Naloxone 0.04-0.1 mg IV"
    - "æˆ– neuromuscular blocker (rocuronium) + æ’ç®¡"
```

**çµ¦è—¥é€Ÿåº¦è¨ˆç®—**ï¼š
```
åŠ‘é‡: 25 mcg (ä¿®æ­£å¾Œ)
ç¨€é‡‹: 25 mcg åŠ å…¥ 10 mL saline = 2.5 mcg/mL
æ¨æ³¨æ™‚é–“: 45 ç§’
æ¨æ³¨é€Ÿåº¦: 10 mL / 45 sec â‰ˆ 13 mL/min
```

---

## ğŸ“Š å®Œæ•´æ™‚é–“-æ¿ƒåº¦æ›²ç·šå°æ¯”

### è¡€æ¼¿æ¿ƒåº¦ï¼ˆCplasmaï¼‰

| Time (min) | æ¨™æº– 50 mcg | ä¿®æ­£ 25 mcg | èªªæ˜ |
|------------|-------------|-------------|------|
| 0 | 3.94 | 1.97 | åˆå§‹æ¿ƒåº¦æ¸›åŠ |
| 1 | 2.8 | 1.4 | å¿«é€Ÿåˆ†å¸ƒ |
| 3-4 | 1.8 | 0.9 | å³°å€¼æ•ˆæ‡‰ |
| 10 | 0.8 | 0.5 | ä»æœ‰æ•ˆæœ |
| 30 | 0.28 | 0.35 | âš ï¸ ä¿®æ­£ç‰ˆæ›´é«˜ï¼|
| 60 | 0.12 | 0.18 | âš ï¸ ä¿®æ­£ç‰ˆæ›´é«˜ï¼|
| 120 | 0.04 | 0.09 | âš ï¸ ä¿®æ­£ç‰ˆæ›´é«˜ï¼|

**é—œéµè§€å¯Ÿ**ï¼š
- å‰ 10 åˆ†é˜ï¼šä¿®æ­£ç‰ˆæ¿ƒåº¦è¼ƒä½ï¼ˆåŠ‘é‡æ¸›åŠï¼‰
- 30 åˆ†é˜å¾Œï¼šä¿®æ­£ç‰ˆæ¿ƒåº¦åè€Œè¼ƒé«˜ï¼ˆæ¸…é™¤è®Šæ…¢ï¼‰
- é€™å°±æ˜¯ç‚ºä»€éº¼ã€Œä½œç”¨å»¶é•·ã€

### æ•ˆæ‡‰å®¤æ¿ƒåº¦ï¼ˆCbrainï¼‰

| Time (min) | æ¨™æº– 50 mcg | ä¿®æ­£ 25 mcg | è‡¨åºŠæ„ç¾© |
|------------|-------------|-------------|----------|
| 0 | 0 | 0 | å°šæœªåˆ°é” |
| 1 | 1.5 | 0.8 | ä¿®æ­£ç‰ˆè¼ƒæ…¢ |
| 3-4 | 2.5 | 1.3 | å³°å€¼ï¼ˆä¸­ç­‰é®ç—›ï¼‰|
| 10 | 1.2 | 0.8 | è¼•åº¦é®ç—› |
| 30 | 0.3 | 0.5 | âš ï¸ ä¿®æ­£ç‰ˆæ›´æŒä¹… |
| 60 | 0.1 | 0.3 | ä¿®æ­£ç‰ˆä»æœ‰æ•ˆ |

---

## ğŸ“ è‡¨åºŠå»ºè­°ç¸½çµ

### ä¿®æ­£å¾Œçš„çµ¦è—¥æ–¹æ¡ˆ

```yaml
drug: Fentanyl
dose: 25 mcg (æ¸›é‡ 50%)
administration:
  route: IV
  rate: slow push over 45 seconds
  dilution: 25 mcg in 10 mL saline
  
expected_effects:
  onset: 3-4 åˆ†é˜
  peak_effect: 4-5 åˆ†é˜ (ç¨å»¶é²)
  duration: 60-90 åˆ†é˜ (å»¶é•·)
  peak_concentration: 1.3 ng/mL (å®‰å…¨ç¯„åœ)

monitoring:
  essential:
    - "æŒçºŒ SpO2 ç›£æ¸¬"
    - "å‘¼å¸é€Ÿç‡ q5min"
    - "æ„è­˜ç‹€æ…‹è©•ä¼°"
  
  intervention_threshold:
    - "RR < 8/min â†’ Naloxone 0.04 mg"
    - "SpO2 < 90% â†’ æ°§æ°£ + Naloxone"
    - "èƒ¸å£åƒµç¡¬ â†’ Naloxone 0.1 mg æˆ– NMB"

rescue:
  drug: Naloxone
  dose: 0.04-0.4 mg IV
  onset: 1-2 åˆ†é˜
  æ³¨æ„: "Naloxone t1/2 çŸ­ï¼ˆ30-60 minï¼‰ï¼Œå¯èƒ½éœ€è¦é‡è¤‡çµ¦è—¥"
```

### èˆ‡æ¨™æº–åŠ‘é‡çš„å°æ¯”

| é …ç›® | æ¨™æº– 50 mcg | ä¿®æ­£ 25 mcg |
|------|-------------|-------------|
| å³°å€¼æ¿ƒåº¦ | 2.5 ng/mL | 1.3 ng/mL âœ… |
| èµ·æ•ˆæ™‚é–“ | 3-4 min | 4-5 min |
| ä½œç”¨æŒçºŒ | 30-45 min | 60-90 min âœ… |
| å‘¼å¸æŠ‘åˆ¶é¢¨éšª | ä¸­ | ä½ âœ… |
| éœ€è¦è¿½åŠ  | 30 min å¾Œ | 60 min å¾Œ |

**é—œéµå„ªå‹¢**ï¼š
- âœ… æ›´å®‰å…¨çš„å³°å€¼æ¿ƒåº¦
- âœ… ä½œç”¨å»¶é•·ï¼ˆä¸éœ€é »ç¹è¿½åŠ ï¼‰
- âœ… é™ä½å‘¼å¸æŠ‘åˆ¶é¢¨éšª
- âš ï¸ èµ·æ•ˆç¨æ…¢ï¼ˆä½†å¯æ¥å—ï¼‰

---

## ğŸ”¬ ä¿®æ­£å› å­çš„ç›¸å°é‡è¦æ€§

### å®šé‡åˆ†æ

| ä¿®æ­£å› å­ | åƒæ•¸å½±éŸ¿ | è‡¨åºŠå½±éŸ¿ | å„ªå…ˆåº¦ |
|----------|---------|---------|--------|
| é«”è„‚ç‡ 30% | Vdss +25% | æŒçºŒå»¶é•· +20% | â­â­ |
| Midazolam (PK) | CL -30% | åŠè¡°æœŸ +40% | â­â­â­ |
| Midazolam (PD) | - | å‘¼å¸æŠ‘åˆ¶ Ã—3 | â­â­â­â­ |
| è€å¹´ 65 æ­² | CL -15% | åŠè¡°æœŸ +18% | â­â­ |
| Slow push | - | é¿å…èƒ¸å£åƒµç¡¬ | â­â­â­â­ |

**çµè«–**ï¼š
- ğŸ”´ **æœ€é—œéµ**ï¼šMidazolam å”åŒå‘¼å¸æŠ‘åˆ¶ã€Slow push
- ğŸŸ¡ **ä¸­ç­‰é‡è¦**ï¼šè—¥ç‰©äº¤äº’ä½œç”¨ (PK)
- ğŸŸ¢ **æ¬¡è¦**ï¼šé«”è„‚ç‡ã€è€å¹´

---

## ğŸ’¡ é€™å€‹æ¡ˆä¾‹å±•ç¤ºäº†ä»€éº¼ï¼Ÿ

### Agent éœ€è¦çŸ¥é“çš„ vs NSForge æä¾›çš„

**Agent è‡ªå·±çŸ¥é“**ï¼š
- âœ… Fentanyl åŸºæœ¬è—¥å‹•å­¸
- âœ… å¦‚ä½•ç”¨ sympy-mcp è¨ˆç®—
- âœ… è—¥ç‰©äº¤äº’ä½œç”¨çš„ã€Œæ¦‚å¿µã€

**Agent å¯èƒ½ä¸çŸ¥é“ï¼ˆéœ€è¦ NSForgeï¼‰**ï¼š
- âŒ é«”è„‚ç‡ 30% å° Vdss çš„ã€Œç¢ºåˆ‡ã€å½±éŸ¿ä¿‚æ•¸ (Ã—1.25)
- âŒ Midazolam å° CL çš„ã€Œç¢ºåˆ‡ã€å½±éŸ¿ (Ã—0.7)
- âŒ å‘¼å¸æŠ‘åˆ¶æ˜¯ã€Œå”åŒã€è€Œéã€Œç›¸åŠ ã€(Ã—3 not Ã—2)
- âŒ Slow push çš„ã€Œç¢ºåˆ‡ã€é€Ÿåº¦è¦æ±‚ (>30 sec)
- âŒ ä½•æ™‚è©²æ¸›é‡ã€æ¸›å¤šå°‘ (50%)

### NSForge çš„åƒ¹å€¼

```
NSForge = å°ˆå®¶ç¶“é©—çš„ç³»çµ±åŒ–ç·¨ç¢¼

æä¾›:
1. æª¢æŸ¥æ¸…å–®ï¼ˆä¸è¦éºæ¼ï¼‰
2. ä¿®æ­£ä¿‚æ•¸ï¼ˆç²¾ç¢ºæ•¸å€¼ï¼‰
3. è‡¨åºŠè­¦ç¤ºï¼ˆå®‰å…¨é—œéµï¼‰
4. å·¥ä½œæµç¨‹ï¼ˆå¦‚ä½•æ‡‰ç”¨ï¼‰
```

---

**Status**: å®Œæ•´ä¿®æ­£è¨ˆç®—å®Œæˆ  
**Framework Used**: Three-compartment PK model + Clinical modifications  
**Tools Used**: sympy-mcp (è¨ˆç®—) + NSForge (ä¿®æ­£å»ºè­°)  
**Educational Value**: å±•ç¤ºç³»çµ±åŒ–ä¿®æ­£çš„é‡è¦æ€§

**âš ï¸ é†«ç™‚å…è²¬è²æ˜**: æ­¤è¨ˆç®—åƒ…ä¾›æ•™è‚²ç›®çš„ï¼Œå¯¦éš›è‡¨åºŠç”¨è—¥å¿…é ˆç”±åˆæ ¼é†«ç™‚äººå“¡è©•ä¼°ã€‚
